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Abstract  
 
Background Problem gambling-specific cognitive therapy (CT) and behavioural (exposure-based) 
therapy (ET) are two core cognitive-behavioural techniques to treating the disorder, but no studies 
have directly compared them using a randomised trial.  
Aims To evaluate differential efficacy of CT and ET for adult problem gamblers at a South 
Australian gambling therapy service.  
Methods Two-group randomised, parallel design. Primary outcome was rated by participants using 
the Victorian Gambling Screen (VGS) at baseline, treatment-end, 1, 3, and 6 month follow-up.  
Findings Of eighty-seven participants who were randomised and started intervention (CT=44; 
ET=43), 51 (59%) completed intervention (CT=30; ET=21). Both groups experienced comparable 
reductions (improvement) in VGS scores at 12 weeks (mean difference -0.18, 95% CI: -4.48 to 4.11) 
and 6 month follow-up (mean difference 1.47, 95% CI: -4.46 to 7.39).  
Conclusions Cognitive and exposure therapies are both viable and effective treatments for problem 
gambling. Large-scale trials are needed to compare them individually and combined to enhance 
retention rates and reduce drop-out. 
 
Keywords: Problem gambling, cognitive therapy, exposure therapy, randomised controlled trial. 
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Introduction 
 
Maladaptive gambling behaviour is harmful to individuals, families, and communities with 
consequences including financial ruin, broken marriages, problems with the law, depression, anxiety 
and suicide. There is an urgent need to identify and develop effective treatments for problem 
gambling that are consistent with the inclusion of Gambling Disorder as an addiction in DSM-5 
(American Psychiatric Association, 2013). The current evidence-base for gambling treatments 
suggests that psychological interventions, mainly variations of cognitive behavioural therapy (CBT), 
are the most promising (Cowlishaw et al., 2012).  
 
The theoretical underpinnings of CBT include cognitive and psychobiological processes which are 
the basis of two dominant approaches to explaining decision-making during gambling (Clark, 2010). 
Cognitive therapy (CT) for problem gambling focuses on teaching the concept of randomness, 
increasing awareness of inaccurate perceptions and restructuring erroneous gambling beliefs 
(Ladouceur et al., 2001). Treatments that target gambling related psychobiological states (e.g. the 
“urge” to gamble) are predominantly behavioural (exposure-based) (Battersby, Oakes, Tolchard, 
Forbes, & Pols, 2008; Oakes, Battersby, Pols, & Cromarty, 2008; Tolchard, Thomas, & Battersby, 
2006). Of the few randomised trials that have investigated behavioural (exposure-based) techniques 
for disordered gambling over the past 30 years none have attempted to isolate and compare their 
efficacy with pure cognitive therapy (Grant et al., 2009; McConaghy, Armstrong, Blaszczynski, & 
Allcock, 1983; McConaghy, Blaszczynski, & Frankova, 1991). It is important to dismantle combined 
CBT approaches to determine if each core component can be delivered independently and if one is 
more efficacious than the other. This has major clinical and policy implications if single modalities 
can be as efficacious and delivered in less time than combined approaches.   
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Therefore, in this randomised controlled trial, the research question we addressed was: Among 
treatment seeking problem gamblers can exposure therapy alone improve gambling related outcomes 
across intervention period and 6-month follow-up compared with cognitive therapy alone? The 
broader aims of the study were to establish whether exposure and cognitive therapy for problem 
gambling could be isolated, manualised and administered in a reliable and consistent manner across 
therapists whilst maintaining fidelity. As a phase II study, it would provide the basis for a phase III 
randomised trial comparing cognitive, exposure and combined cognitive and exposure therapy to 
assess the relative benefits of the individual and combined elements of CBT and determine 
underlying mechanisms of change.  
 
Methods 
 
Study design and participants 
A detailed description of the study protocol has been published elsewhere (Smith, Battersby, Harvey, 
Pols, & Ladouceur, 2013). Comparing outcomes of cognitive and exposure therapy for problem 
gamblers was conducted using a two-group randomised, parallel design, with outcomes assessed up 
to 9 months after randomisation for treatment seeking problem gamblers. The study site was the 
Statewide Gambling Therapy Service (SGTS) in South Australia. The service offers free mental 
health and cognitive-behavioural treatment for help-seeking problem gamblers in key geographical 
areas. We recruited 99 participants from consecutive new outpatients attending SGTS Flinders site in 
South Australia between April, 2011 and April, 2012, and completed outcome data collection 
January, 2013.  
 
To assess study eligibility, an independent clinician conducted semi-structured interviews by 
telephone with treatment seeking problem gamblers who contacted SGTS during the recruitment 
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period. The interview comprised of an assessment of demographic data, recent gambling activities, 
and administration of  the well-validated South Oaks Gambling Screen (SOGS) as a screening 
questionnaire (Lesieur & Blume, 1987). The SOGS is a 20 item questionnaire based on DSM criteria 
for pathological gambling using a binary response method.  It has previously been used in a 
population-based cross-sectional study of South Australian adults when administered by telephone 
(Gill, Dal Grande, & Taylor, 2006). A score of 5 or more is indicative of probable pathological 
gambling. In gambling treatment samples the scale has good reliability, exhibits high correlations 
with DSM-IV diagnostic criteria, and good to excellent classification accuracy (Stinchfield, 2002). 
 
Study eligibility was based on the following inclusion criteria: 18 years of age or older; treatment 
seeking for problem gambling with electronic gaming machines (EGM’s); not involved in a 
concurrent gambling treatment program; gambled in the past month using EGM’s without any 
psychological treatment for problem gambling in the previous 12 months; willing to: participate in 
the study; to read and respond to self-rated questionnaires written in English; be randomised to one 
of two psychological treatments; provide follow-up data; have treatment sessions audio recorded; as 
well as scoring 5 or greater on the SOGS; and not suicidal, exhibiting acute psychosis or mania or 
experiencing significant mental distress such that  the problem gambler would not be able to 
participate fully in the treatment offered or research procedures. Patients were not excluded if they 
exhibited co-morbid anxiety disorders, depression, personality disorders or drug and alcohol abuse.  
 
The study received approval from the Southern Adelaide Health Service / Flinders University Human 
Research Ethics Committee, and was registered with the Australian New Zealand Clinical Trials 
Registry (ACTRN12610000828022) at the trials inception.  
 
Randomisation  
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Eligible individuals were randomly assigned to one of two treatment groups with 1:1 allocation ratio 
before their pre-treatment assessment with a therapist. From the trial outset, randomisation was 
blocked to increase the likelihood of equal group sizes, using a standard permutated block algorithm 
in which block sizes were randomly chosen from 2, 4, and 6 to protect concealment. To ensure 
balance on potential confounders, block randomisation within strata was used. Stratification variables 
were age, gender and SOGS scores for gambling severity. Based on previous SGTS data, age was 
stratified as 18 - 42 years, and 43 years or more (Smith et al., 2010). Recent population data for 
South Australia showed a median age of 39.5 years (Australian Bureau of Statistics, 2011). 
Gambling severity was stratified according to previous treatment- seeking problem gamblers SOGS 
scores of either 5 - 11 or 12 - 20 (Riley, Smith, & Oakes, 2011). A biostatistician independently 
generated random sequences for each stratum using Stata version 11.1 software and delivered these 
to the clinical trials call centre of a centrally located hospital pharmacy. Staff enrolling and referring 
participants, collecting and entering data and administering interventions did not know in advance 
which treatment the next participant would receive.  
 
Masking 
In this trial, therapists knew what treatment they were administering and participants were provided 
with information that rationalised and described their assigned therapy protocol. It was intended that 
participants were masked to the study hypothesis in order to help limit the likelihood for self-report 
bias. Participant information sheets referred to treatments as “well known and commonly used 
psychological treatments”. To avoid contamination of masking, SGTS administration staff members 
were instructed not to reveal specific treatment labels to any participants and therapists not to reveal 
the alternative treatment label.  
 
Procedures 
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Table 1 shows a summary of therapy sessions and manuals are available from authors upon request. 
Participants in each group received, on average, twelve 60-minute individual treatment sessions 
conducted at weekly intervals. For this study, both CT and ET manuals were written as a session-by-
session guide for therapists treating individuals with a gambling disorder where EGMs were the main 
form of gambling. Participants in both groups were given home exercises with rationale and 
instructions and a review of these was conducted at the beginning of each session. After eligibility 
screening by the research assistant and randomised allocation to the intervention, all participants 
were provided with a screening interview by the allocated CT or ET trial therapist at study 
commencement that comprised a gambling focused cognitive behavioural assessment including 
DSM-IV-TR criteria for identifying pathological gambling. All subsequent therapy sessions were 
audio recorded and 20% were randomly selected from early, mid, and late study phases and checked 
for therapy fidelity. For this, a 10 item checklist was developed based on the Cognitive Therapy 
Scale (CTS) which is an 11-item instrument with good reliability when used by experienced 
clinicians (Young & Beck, 1980). Treatment drop-out was determined using the approach based on 
therapists’ judgement of participant progress up to the point of self-initiated termination (Melville, 
Casey, & Kavanagh, 2007). Specifically, participants were classified as drop-outs if they stopped 
attending therapy before completion of the therapy program- either without discussion with the 
therapist or when the therapist believed the participant was in need of further therapy. 
 
Table 1 here 
 
Cognitive therapy 
The therapists at SGTS had previous experience in administering CT in groups with treatment being 
structured according to a manual that outlined procedures over 12 weekly sessions. The training and 
supervision of cognitive therapists for the individual format in this study was provided by RL 
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(Ladouceur et al., 2003; Ladouceur et al., 2001) and a registered clinical psychologist who had 
received extensive training in CBT protocols. The supervisors also conducted therapist fidelity 
checks for both CT and ET groups. Cognitive therapy was provided by two cognitive behavioural 
therapists with qualifications in clinical psychology and who had 4 and 6 years respectively of 
practice experience, including 2 years in treating individuals with gambling disorders.  
 
Exposure therapy 
The SGTS had already developed treatment methods and a treatment manual for the conduct of ET 
for up to 12 individual weekly sessions which was in use by therapists (Battersby et al., 2008; 
Tolchard et al., 2006). Therapists who administered ET received supervision from MB (Battersby et 
al., 2008). Fidelity checks of audio recordings were also conducted by MB and RP (Battersby et al., 
2008; Oakes et al., 2008). Exposure therapy was provided by two cognitive behavioural therapists 
with post-graduate qualifications in CBT; a registered mental health nurse and an honours 
psychology graduate with 10 years and 3 years respectively of clinical experience including 2 years 
in delivering CBT treatments to gambling clients of SGTS using the ET program.  
 
Outcomes 
We undertook assessments at baseline, post-treatment (12 weeks) and follow-up at 1, 3 and 6 month 
post-treatment.  Follow-up questionnaires were mailed to both treatment completers and treatment 
drop-outs with a pre-paid self-addressed envelope. To improve response rates to mailed 
questionnaires, multiple contacts were implemented with phone calls and reminder letters. Also, all 
participants were offered honorarium gift vouchers to the value of $10 at completion of therapy; $20 
at 3 months follow-up; and $25 at 6 months follow-up.  
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The participant-rated primary outcome measure was the Victorian Gambling Screen (VGS) harm to 
self- subscale (Likert scoring 0, 1, 2, 3, 4; range 0-60; score of 21+ identifies a person as a problem 
gambler) relating to the person’s experiences in the previous 4 weeks. It is a valid and reliable 
instrument with concurrent validity with other measures of problem gambling including SOGS but 
extends the score range (Tolchard & Battersby, 2010). It also has shown similar properties in 
construct validity to the Canadian Problem Gambling Index (CPGI) on a number of problem 
gambling correlates (e.g. ‘self-rating of problem’; ‘wanted help’; and ‘suicidal tendencies’) 
(Jacobson, Dobson, Traux, et al., 1996). It was chosen as the primary outcome measure because it 
was developed and validated in Australia and it has a one month time frame for reporting, hence 
enabling measurement of change during and after treatment. 
 
For secondary outcomes, measures relating to gambling behaviours using EGMs were: frequency of 
gambling in previous month, number of hours spent on gambling activities in previous month, and 
amount spent on gambling activities in previous month. We also assessed gambling related 
cognitions with the gambling related cognitions scale (GRCS) (Raylu & Oei, 2004a), gambling urges 
with the gambling urge scale (GUS) (Raylu & Oei, 2004b), psychological distress using Kessler 10 
(K10) (Andrews & Slade, 2001), and overall disability with the work and social adjustment scale 
(WSAS) (Mundt, Marks, Shear, & Greist, 2002). These secondary outcomes were a subset of those 
specified in the protocol, selected as most relevant for this report. Following an explanation of 
treatment rationale and protocol in session one, participants were asked to rate their confidence in 
treatment (from 0 = extremely unconfident to 6 = extremely confident) and belief in treatment logic 
(from 0 = extremely illogical to 6 = extremely logical) at commencement of session two.  At 
treatment completion participants were asked to rate their views on satisfaction with treatment 
received (from 0 = extremely unsatisfied to 6 = extremely satisfied). 
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Statistical analysis 
In our sample size calculations, we assumed a correlation between follow-up measures of r = 0.7 
(Frison & Pocock, 1992). Based on a type I error rate of 5% , power of 90%, two-tailed test, and a 
VGS standard deviation of 10.2 units (Smith et al., 2010), to detect a significant difference of 8% 
(i.e. 4.8 points on the scale) in mean VGS scores between the ET and CT groups, 50 participants 
were required in each group. Given the treatment drop-out rate experienced in the SGTS treatment 
programme (approximately 30%) we therefore needed to recruit 65 participants in each group of the 
study giving a total sample size of 130 participants.  
 
The primary analysis used all available data and followed an intent-to-treat principle to investigate 
any statistically significant differences in primary and secondary outcomes over time between 
cognitive and exposure therapy. Secondary analyses were conducted based on ‘as treated’ and ‘per 
protocol’ approaches within a counterfactual framework using inverse probability weighting (IPW) 
(Hernan & Hernandez-Diaz, 2012). The IPW uses the inverse of the probability of being in the 
observed treatment group. These probabilities were obtained by fitting a logistic regression model of 
therapy group (ET = 1; CT = 0) on age, gender and baseline gambling severity (VGS). From this 
model, probabilities (pr) were firstly calculated and then IP weights for ET were calculated by taking 
the inverse of 1 - pr, and weights for CT participants were similarly obtained. These weights were 
then used to calculate weighted means of the outcome measures for both ET and CT and contrasted 
to obtain an average treatment effect of ET versus CT at post-intervention and 6 month follow-up. 
Due to a relatively small sample size, robust standard errors were calculated from bootstrap samples. 
Where results did not differ between the three approaches, only results from the primary analysis and 
per protocol analysis are reported.  
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Generalised mixed-effects models were used in the analysis of repeated measures for primary and 
secondary continuous and categorical outcomes. Fixed effects (time- invariant variables) in models 
were intervention group (CT or ET), time in continuous form (intervention period and follow-up), 
and interaction between group and time. A quadratic term for time was also tested to allow for 
possible non-linear effects. A preliminary model assessed for a therapist effect across time and was 
to be included in the main analysis if statistically significant. Random effects in the model were at 
study participant level, and represented an upward or downward shift in the outcome measure from 
an average regression line and rate of change. An unstructured variance-covariance pattern was 
specified for the random effects. This meant that participant- specific baseline scores (intercepts) and 
rates of change across time (slopes) were assumed to be correlated. This assumption was tested by 
comparing the model with the unstructured pattern to a model with an independent structure (all 
correlations zero) using a likelihood-ratio test. Maximum likelihood estimation was used where both 
fixed effects and random effects contributed to the estimation of model parameters. A 
heteroskedastic random-effects model was also performed to assess if individuals within CT and ET 
had similar variability in rates of change in VGS scores across time when compared to the main 
model. Statistical analyses were conducted using Stata 12.0 (StataCorp, 2013) and the user-written 
program gllamm (generalised linear latent and mixed models) (Skrondal & Rabe-Hesketh, 2003). 
 
A secondary post-hoc analysis compared VGS scores across time between therapy completers and 
non-completers using a mixed-effects model. Model specification included an interaction term 
between therapy completion status and time, and adjusted for stratification variables to account for 
the observational nature of this subset of data.  The estimate of the difference in the adjusted means 
for completers versus drop-outs was then calculated at each time point as well as 95% confidence 
intervals.   
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Finally, the proportion of participants who had VGS scores in the non-problem gambling range (< 
21) at 6 month follow-up or 3 months where 6 month data was missing were assessed using Fisher’s 
exact test. In addition, a reliable change index (RCI) was calculated to determine how much 
therapeutic change occurred from baseline to follow-up using continuous VGS data. This was 
calculated using the formula SEdiff = SDb∗ √2 ∗ √1 − 𝑟 where SEdiff was the standard error of 
difference, SDb was baseline standard deviation and r was Cronbach’s alpha coefficient for VGS at 
baseline (Jacobson & Truax, 1991). A risk difference statistic was then calculated to determine if 
there were any differences between  proportions of individuals in each therapy group who 
experienced a reliable change.Effect size statistics were also produced for comparisons of mean 
observed scores(Cohen’s d) (Cohen, 2013) and associations of nominal variables  (Cramer’s V or phi 
for 2 x 2 contingency table) (Cramér, 1946). The interpretation of Cohen’s d may be guided by the 
conventional standard of 0.2 to 0.49 as small, 0.5 to 0.79 as medium and 0.8 or above as large. For 
Cramer’s V, less than 0.19 is weak, 0.2 to 0.29 is moderate and 0.3 or above is large. For 
nonparametric between-group tests, the Mann-Whitney statistic  was calculated as a measure of 
effect size (Conroy, 2012). For statistically significant values, the probability of an observation in 
one therapy group having a true value higher than an observation in the alternative group was then 
reported. To interpret this probability in terms of Cohen’s d effect sizes, the statistic 𝑟 = 𝑧
√𝑁
⁄  was 
also calculated (Fritz, Morris, & Richler, 2012).  
 
RESULTS 
 
Participant recruitment and flow 
The flow of participants through each stage of the study is shown in Figure 1. Participants were 
recruited from 151 consecutive referrals to SGTS. The most common reason for study exclusion was 
non-EGM use as the primary form of problem gambling. Of the 99 participants randomized, 12 did 
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not attend and commence the allocated intervention. One participant allocated to the CT group 
received ET due to inconsistent application of the study protocol. No significant differences were 
found between intervention starters and non-starters on stratification variables age (p = 0.395, d = 
0.26, 95% CI: -0.34 – 0.87), SOGS scores (P = 0.170, d = 0.43, 95% CI: -0.18 – 1.03) or gender 
distribution (p = 0.970, Cramer’s V = -0.004). 
 
Figure 1 here 
 
For all participants, median time of engagement in the study from baseline to final data collection 
point was 40.9 weeks where 50 % of participants had times between 17 and 59 weeks (IQR = 42 
weeks) and 25 % less than 6.9 weeks. Mean follow-up time was 6.5 weeks (SD = 2.7; Range: 3.7 - 
17 weeks) for one month assessment, 15.6 weeks (SD = 3.7; Range: 8.7 – 27.4 weeks) for 3 month 
assessment, and 29.6 weeks (SD = 5.4; Range: 19.9 – 46.1 weeks) for 6 month assessment.  
 
Baseline characteristics 
Baseline characteristics for n=87 participants are presented in Table 2. When stratifying VGS at cut 
score 21 there were 81(94.2%) classified as problem gamblers. For DSM-IV-TR criteria there were 
83(95.4%) diagnosed as pathological gamblers based on scores of 5 or more when assessed by a 
therapist at study commencement. The distribution of scores for psychological distress as measured 
by K10 were 22(25.3%) self-reporting minimal to mild levels, 19(21.8%) as moderate, and 
46(52.9%) in the severe range. For participants perspective of their functional ability/impairment 
using WSAS, 25(28.7%) were in the sub-clinical range, 40(46%) with significant impairment, and 
22(25.3%) in the moderate to severe range. 
 
Table 2 here 
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Implementation of interventions 
For treatments implemented, the case volume for CT therapist one was 28 participants and 15 for 
therapist two.. For ET, the case volume for therapist one was 27 participants and 17 for therapist two. 
For participants who started an intervention (n=87), the median number of CT sessions was 8.5 
(IQR, 4 - 11.5) and 5 for ET sessions (IQR, 3 - 9) (p = 0.046). The effect size statistic for this 
difference was small (𝑟 = 0.21) and meant that the probability of a CT participant having a higher 
number of treatment sessions than an ET participant was 62.4%. A significant difference was also 
found between mean duration of CT sessions (51.9 minutes, SD =16.3) and mean duration of ET 
sessions (43.3 minutes, SD = 20.9) (p < 0.001, d = 0.47, 95% CI: 0.29 – 0.64). There was no 
significant difference in median number of weeks that participants were engaged in treatment 
between CT (Median = 13.5; IQR, 6.9 – 21.6) and ET (Median = 9.6; IQR, 2.7 - 20.7) (p = 0.316). 
There was no significant difference in rate of therapy sessions attended per week between ET 
(Median = 0.58; IQR, 0.40 – 0.95) than CT (Median = 0.62; IQR, 0.47 – 0.77) (p = 0.814) where ET 
values were slightly lower but more variable than CT. 
 
Based on therapists’ judgement, 41% (36/87) of participant’s were classified as treatment drop-outs: 
31.8 % (14) for CT and 51.2 % (22) ET (p = 0.067, Cramer’s V = -0.20). Of these, 66.7% (24/36) 
attended 1 to 3 sessions (CT, 8/14; ET, 16/22) (p = 0.334, Cramer’s V = -0.16). For treatment 
completers (51/87), there was no significant difference between median number of CT sessions 
(Median= 9.5; IQR, 8 - 14) and ET sessions (Median=9; IQR, 7 - 11) (p = 0.218). Similarly, there 
was no significant difference in duration of treatment episode (weeks) between CT (Median = 16.6; 
IQR, 11.9 - 24.1) and ET (Median = 18.1; IQR, 12.0 - 28.7) (p = 0.893). 
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Therapy fidelity 
All therapy sessions were audio recorded (n = 526). Of all the interventions started, 52 out of 87 
participants (59.8%, 25 for CT, 27 for ET) were randomly selected for independent scoring of 
therapist fidelity with assigned treatment manual. A total of 107 out of 526 (20 %) recordings were 
evaluated and comprised of 76 unique sessions (14.4%, 39 for CT, 37 for ET) and 31 for inter-rater 
checking. The evaluations were stratified according to study phase of treatment session: 30 (28.04%) 
for early phase (April - August, 2011), 36 (33.5%) mid-phase (September 2011 - January 2012), and 
41 (38.32%) in the final phase (February - June, 2012). For CT, 27 (25.23%) evaluations were 
carried out for therapist one, and 28 (26.17%) for therapist two. For ET, 27 (25.23%) evaluations 
were carried out for therapist one and 25 (23.36%) for therapist two. 
 
The overall mean treatment fidelity score was 98.5% for CT (SD = 4.4%) and 99.5% for ET (SD = 
2.8%). These scores did not significantly differ between the two groups where the mean difference 
was 1.1% (95% CI: 0.4% - 2.5%, p = 0.142). To assess inter-rater agreement, mean difference (bias 
statistic) and limits of agreement were calculated based on the formula for small sample sizes (bias ± 
2*SD) (Krippendorff, 2012) where values closer to zero indicate stronger agreement. The mean 
difference between each pair of rater’s observations was 2.1%. This result, in conjunction with an 
insignificant difference between mean scores (p = 0.710) indicated that rater’s observations tended to 
agree. In future study samples, the difference in rater’s osbervations would be expected to lie within 
the limits of agreement of -11.3% to 15.6% approximately 95% of the time.  
 
Analysis of primary outcome 
Participant views about treatment are shown in Table 3. For the primary outcome measure VGS, the 
pairwise correlation coefficients for follow-up measurement occasions were in the range 0.44 to 0.73 
and mean value of 0.63. In terms of effect size, the mean correlation value was a close approximation 
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to an assumed value of 0.7 in the sample size calculation. Also, baseline SD values in both groups 
(Table 2) were close to the assumed value used for sample size calculations. However, there was 
considerable variation in follow-up SD values for CT (12.90 to 19.10) and ET (8.86 to 16.66). The 
observed individual trajectories of scores over time by therapy group (Figure 2) indicated that trends 
were generally nonlinear for treatment completers. Different trends are observed for CT and ET 
completers with more CT completers relapsing post treatment and more ET non-completers 
improving over time. For CT participants, VGS data were available for 79.5% (35/44) on at least one 
occasion post- baseline assessment and 70% (31/44) provided at least one set of post- treatment data. 
For ET participants, VGS data were available for 72.1% (31/43) on at least one occasion post- 
baseline assessment and 65% (28/43) provided at least one set of post-treatment data. In both groups, 
the availability of data at 6 month follow-up was, at least partly, influenced by the proximity of 
participant’s study enrolment date relative to study completion date. 
 
Table 3 here 
 
Figure 2 here 
 
Using all available data (n = 87), results from between group comparisons for VGS using linear 
mixed-modelling are shown in Table 4 for baseline, end of treatment, 1, 3 and 6 month follow-up. 
The average number of outcome assessments per individual was 2.9 (Range, 1 - 5) and a total of 254 
observations. In a preliminary analysis, there was no significant therapist effect across time (𝜒2(3) =
1.58, p = 0.664). For the main analysis, there was no significant difference between the two groups 
in rate of change in scores across all time points (𝛽(𝐸𝑇−𝐶𝑇)= 0.07, 95% CI: -0.12 - 0.26, p = 0.477). 
There was a significant reduction (improvement) in VGS scores within treatment groups during 
intervention and follow-up time periods (P < 0.001). On average, the VGS score decreased by 0.71 
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points per week (95% CI: 0.58 - 0.83) in CT participants and 0.89 points per week (95% CI: 0.74 - 
1.03) in ET participants.  
 
The estimated random intercept standard deviation for VGS was 6.3 points (95% CI: 4.29 - 9.38) and 
this considerable variation between individuals is indicated from baseline scores in Figure 2. There 
was no significant correlation between individual baseline VGS scores (intercepts) and rate of 
improvement over time (slope) from the comparison of models with an unstructured variance-
covariance pattern of random effects versus independent structure (p = 0.149). A heteroskedastic 
random-effects model indicated that the variability in participant-specific deviations from the 
average change in VGS scores across time was the same for CT and ET groups (𝜒2(2) = 1.77, p = 
0.413).  
 
A per protocol analysis was conducted to determine how well the therapies worked under ‘near-
perfect’ conditions.  The estimated mean VGS scores at 12 weeks for ET and CT was 8.18 points 
(95% CI: 2.77 – 13.59) and 7.77 points (95% CI: 1.93 – 13.61) respectively. There was no significant 
difference between therapy groups for this analysis (𝛽𝐶𝑇 𝑣𝑠 𝐸𝑇 = - 0.41, 95% CI: -8.08 – 7.26, p = 
0.916). This analysis showed an additional improvement for treatment completers when compared to 
estimates obtained from the intent-to-treat analysis which comprised of data for both therapy 
completers and non-completers (Table 4). At 6 month follow-up the estimated mean VGS scores for 
ET and CT was 4.57 points (95% CI: 1.01 – 8.13) versus 10.38 points (95% CI: 4.09 – 16.66) (p = 
0.165) respectively. These  estimates were less precise because of missing data and bootstrap 
sampling to account for the small sample size. However, upper confidence limits for both groups 
were in the non-problem gambling range based on VGS cut score of 21 or less. 
 
Table 4 here 
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Analysis of secondary outcomes 
Results from between group comparisons for continuous secondary outcome measures are shown in 
Table 4. For gambling urges, there was no significant difference between the two groups in rate of 
change in scores over time (𝛽(𝐸𝑇−𝐶𝑇)= -0.05, 95% CI: -0.19 - 0.09, p = 0.463). There was a 
significant reduction (improvement) within treatment groups across time (p < 0.001). On average, the 
GUS score decreased by 0.24 points per week (95% CI: 0.15 – 0.34) in CT participants and 0.38 
points (95% CI: 0.27 – 0.48) in ET participants. For gambling related cognitions there was no 
significant difference between groups (𝛽(𝐸𝑇−𝐶𝑇)= 0.04, 95% CI: -0.25 – 0.33, p = 0.806) but a 
significant reduction (improvement) in scores within treatment groups (p < 0.001). On average, the 
GRCS score decreased by 0.97 points per week (95% CI: 0.77 – 1.16) in CT participants and 1.25 
points (95% CI: 1.02 – 1.47) in ET participants. For measures of depression and anxiety (K10) there 
was no significant difference between groups (𝛽(𝐸𝑇−𝐶𝑇)= -0.001, 95% CI: -0.12 – 0.11, p = 0.977) as 
well as for overall disability with work and social adjustment (WSAS) (𝛽(𝐸𝑇−𝐶𝑇)= -0.03, 95% CI: -
0.13 – 0.08, p = 0.614) but significant reductions (improvement) in scores on each measure within 
groups (p < 0.001).  
 
For time spent gambling in previous month, hours was transformed using natural logarithm 
(loge(hours)) and the inverse of model estimates (exp(hours)) were then calculated for interpretation.  
There was no significant difference between the two groups in rate of change in hours over time 
(𝛽(𝐸𝑇−𝐶𝑇)= -0.01, 95% CI: -0.03 – 0.01, p = 0.322). There was a statistically significant reduction 
(improvement) in hours gambled within treatment groups during intervention and follow-up time 
periods (p < 0.001). On average, hours gambled decreased by 0.97 per week (95% CI: 0.95 – 0.98) in 
CT participants and 0.95 (95% CI: 0.94 – 0.97) in ET participants.  
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Results for amount spent in previous month using a random-intercept proportional odds model 
showed the odds ratio of more money spent per week was 0.78 (95% CI: 0.73 to 0.84) for the CT 
group. The odds ratio for ET was estimated as 0.82 (95% CI: 0.75 to 0.89). There was no significant 
difference between treatment groups over time (OR = 1.01, 95% CI: 0.98 – 1.04, p = 0.371). The 
odds ratio of more frequent gambling per week was 0.77 (95% CI: 0.73 to 0.83) for the CT group 
and 0.78 (95% CI: 0.74 to 0.83) for ET group. There was no significant difference between treatment 
groups over time (OR = 1.01, 95% CI: 0.98 – 1.04, p = 0.448). 
 
Secondary post-hoc analysis 
Results from a mixed-effect model showed that therapy completers in both study groups experienced 
a significantly greater  rate of reduction (improvement) in VGS scores across time compared to drop-
outs (p = 0.010). Figure 3 shows a plot of the estimate of the difference in the adjusted means for 
completers versus drop-outs at each time point and 95% confidence intervals. Similar trends 
favouring therapy completers over drop-outs were found on secondary continuous outcome measures 
GUS (p = 0.015), GRCS (p = 0.003) and K10 (p = 0.013) but not WSAS (p = 0.349).  
 
Using VGS cut score of 21 or less for all available data at 6 month follow-up, 82.6% (19/23) of ET 
participants were classified as non-problem gamblers compared to 79.3% (23/29) of CT participants. 
No significant difference was found between group proportions (p = 0.405). Both groups also 
showed a clinically meaningful reduction (improvement) in mean VGS scores (p < 0.001) from 
baseline to follow-up with large effect sizes (CT: d = 2.10, ET: d = 2.53). For RCIs calculated from 
VGS data, 91.3% (21/23) of ET participants showed a reliable therapeutic change at 6 month follow-
up and 8.7% (2/23) showed no real change. For CT participants, 79.3% (23/29) showed a reliable 
change, 17.2% (5/29) no real change and 3.5% (1/29) got worse. There was no significant difference 
between group proportions of RCI outcomes (p = 0.426). The risk difference was also insignificant 
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when comparing outcomes ‘reliable change’ versus ‘no real change’ or ’got worse’ between groups 
(risk difference = 0.15, 95% CI: -0.04 – 0.34). 
 
Figure 3 here 
 
DISCUSSION 
 
To our knowledge this study is the first to test a direct comparison between CT alone and ET alone in 
problem gambling with fidelity testing confirming that there are valid and reliable CT and ET 
techniques that can be taught and delivered in manualised form. Exposure therapy achieved similar 
clinical outcomes as CT alone and gambling-specific CBT programs  typically comprise of CT as the 
core element (Cowlishaw et al., 2012). However, due to a shortfall in participant numbers, a true 
difference between therapy groups of 4.8 points on VGS may have remained undetected.  The 
therapy drop-out rate of 41% was comparable to previous studies involving psychological treatment 
of problem gambling that have ranged from 14% to 50% and median of 38% (Melville et al., 2007). 
Over 66% of drop-outs attended 3 or fewer sessions with a significant proportion improving over the 
study period suggesting that further research is needed to better understand outcomes for this sub-
group.  
 
Due to similar between-group benefits on measures relating to gambling urge and cognitions we 
were unable to identify different causal mechanisms being responsible for translation of CT and ET 
to the expected outcome. Nonetheless, if both cognitive and exposure therapy can mitigate gambling 
urge and cognitions then a more pertinent question relates to the comparative utility of these 
treatments in everyday clinical practice. Behavioural techniques in general are considered more 
parsimonious in terms of delivery than cognitive approaches (Jacobson, Dobson, Truax, et al., 1996). 
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Based on all therapy starters in this study, the average number and duration of ET sessions were 
significantly less than CT sessions. There tended to be more therapy drop-outs in the ET group but 
more CT completers relapsed after initial improvement and more ET drop-outs, receiving only 1-3 
sessions improved by 6 months (Figure 2). This suggests that while CT is more consumable by 
patients, fewer sessions of ET may achieve the same outcomes as more sessions of CT. Perhaps 
therapists could offer either ET or CT alone or a combination of both according to patient preference 
and success. This may lead to more parsimonious treatments and greater retention of patients in 
therapy by flexibly tailoring programs according to individual needs.  
 
Beyond findings of this current study, data in relation to differential drop-out from gambling-specific 
cognitive and exposure therapies is mostly non-existent. In posttraumatic stress disorder (PTSD) and 
obsessive compulsive disorder (OCD) it has been found that cognitive and exposure therapies are 
equally tolerable (Hembree et al., 2003; Van Oppen et al., 1995). Notwithstanding therapy type, it 
has also been suggested that manualised treatments may increase drop-out rates due to systematic 
procedures being less focussed on patients’ concerns in the here and now (Hembree et al., 2003).  
Although we did not collect data in relation to formal diagnoses of co-morbid disorders, it was found 
that over 70% of participants self-reported moderate to severe levels of psychological distress at 
baseline assessment using the K10 instrument. In a previous study involving a large cohort of 
treatment- seekers who attended SGTS, similar prevalence rates were found for 12-month affective 
disorder and anxiety disorder based on Australian normative data (Slade, Grove, & Burgess, 2011; 
Smith, Harvey, Humeniuk, Battersby, & Pols, 2014). Based on the potential for high prevalence rates 
of co-occurring conditions in the present study, the specificity of CT alone or ET alone may have 
been too prescriptive for some participants alongside other mental symptoms. Perhaps those who 
were suffering from co-occurring conditions were too distracted or less willing to focus on a 
structured therapy and therefore self-terminated treatment. 
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The 6 month follow-up data indicated that the majority of treatment gains made by completers of CT 
and ET were clinically meaningful and psychometrically sound for primary outcome measure VGS. 
More specifically, RCIs indicated that the number of participants experiencing actual improvement 
in both groups was greater than the number of participants who experienced no change or got worse 
in problem gambling symptoms. In terms of predicted therapeutic change, both completers and non-
completers showed an initial rapid improvement on the VGS. This may have been partly due to 
regression to the mean or random measurement error (Barnett, van der Pols, & Dobson, 2005).  
 
Beyond study intervention period, improvements for treatment completers appeared to persist for up 
to 6 month follow-up. In previous gambling trials, similar patterns of change have been found on a 
range of symptoms including depression, urge and cognitions where treatments have involved a 
combination of cognitive-behavioural techniques (Carlbring, Jonsson, Josephson, & Forsberg, 2010), 
ET alone (McConaghy et al., 1983) and CT alone (Sylvain, Ladouceur, & Boisvert, 1997). 
Gambling-specific CT and ET teaches skills which the client are asked to use beyond therapy to 
unlearn or extinguish psycho-physiological gambling responses (Battersby et al., 2008). Comparable 
patterns of improvement in short to mid-term follow-up have also been shown in the treatment of 
anxiety disorders using CBT (Clark et al., 2006; Marks, Lovell, Noshirvani, Livanou, & Thrasher, 
1998) where mechanisms of psychological and physiological (arousal) components in response to 
environmental triggers or cues are analogous to those in problem gambling (Battersby et al., 2008).  
 
Strengths and limitations of the study 
A key strength of this study was that all treatment seeking problem gamblers meeting eligibility 
criteria received an active treatment. Also, due to the broad study inclusion criteria, a significant 
proportion of the sample had co-occurring gambling-related problems (e.g. psychological distress) 
and this enhanced the external validity of findings. One of the main limitations of this study was loss 
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of power due to a deficit in the number of participants recruited and this may have resulted in a Type 
II error. Also, the relatively wide 95% confidence intervals reflected a degree of imprecision in 
estimates of differential treatment effects. For example, at 6 month follow-up, the 95% confidence 
interval was compatible with a difference of up to 4 points in favour of ET or a difference of up to 7 
points in favour of CT given the study data. Funding constraints meant that we were unable to extend 
the recruitment period beyond 12 months.   
 
Furthermore, attenuated study power resulted from a higher rate of therapy drop-out than expected 
and greater variability in VGS data at follow-up time points. In order to establish that CT and ET 
treatments are equivalent or non-inferior in a future trial, a much larger number of problem gamblers 
would need to be treated. For example, if there was truly no difference between CT and ET 
interventions, a total of 158 problem gamblers would need to be treated to be 90% sure that the limits 
of a two-sided 80% confidence interval excluded a difference in means of more than 7 points on 
VGS- the upper confidence limit for the treatment effect estimate at 6 month follow-up in this 
present study.  
 
Whilst there was a therapy drop-out rate of 41%, follow-up of all randomised individuals was 
attempted. A strategy to improve post- treatment follow-up rates was to minimise the number of 
attendances required at the study site by sending questionnaires to participants by post. Subsequently, 
we obtained follow-up data from 79.5% (CT) and 72% (ET) of all participants on at least one 
occasion. This enabled a comparison between therapy completers and non-completers in how much 
improvement was achieved. Still, non-response to postal questionnaires may have produced biased 
estimates of therapy effects (Edwards et al., 2002). For example, participants who were classified as 
“drop-outs” may have in fact reached their personal goals early in treatment and consequently 
discontinued with the study based on a decision that any further involvement would not provide 
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additional benefits (Hembree et al., 2003). This may have led to more conservative estimates of 
treatment effects from an intent-to-treat perspective. Future studies should aim to address therapy 
drop-out by combining cognitive and exposure therapies in a flexible manner tailored to each 
participant and data collection rates using electronic data collection e.g., smart phone, text and web-
based data collection systems, and key informant contacts to trace participants.  
 
A further limitation of the study design was the lack of an active control group to account for non-
specific treatment effects. However, a reasonable assumption was made that non-specific effects 
would be approximately similar between study groups due to analogous therapy structures, therapist 
background and experience, and therapeutic environment. Many studies have shown that various 
combinations of cognitive and behavioural therapies are superior to control conditions, including 
absolute effects; hence this study was designed to extend the evidence-base by directly testing 
cognitive and exposure therapies. Also, outcome data were collected from self-report measures and 
therefore participants may have overestimated treatment effects. Because there was a high degree of 
similarity between each therapy in terms of their structured approaches and masking of participants 
to study hypothesis, the influence of any bias in self-ratings was expected to be minimised. Finally, 
the range of measures used in this study were commensurate with recommended minimum features 
for reporting efficacy of treatment in problem gambling (Walker et al., 2006). Although there was 
potential for type I error due to multiple significance tests, it was improbable that any statistical 
adjustment would have influenced the main trial conclusions.  
 
Implications for research 
Further research in gambling disorder is required to test whether exposure alone is as efficacious as 
CT alone or combined as has been found for anxiety disorders (Marks et al., 1998). Future studies 
would also benefit from strategies to increase both therapy uptake and completion of follow-up data 
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to better determine relative efficacy of these treatments. Also, in addition to therapist fidelity, the 
measurement of participant alliance to therapy would augment the evidence relating to putative 
mechanisms of therapeutic change. This phase II study provides the clinical and statistical basis with 
effect sizes to determine sample size calculations for a definitive phase III randomised controlled 
dismantling trial comparing exposure, cognitive therapy and combined exposure and cognitive 
therapy with a control group. This will add to theory and clinical practice by testing the relative 
efficacy and retention of isolated against combined modalities and test underlying mechanisms of 
change potentially advancing knowledge of CBT for problem gambling to that achieved by the 
seminal dismantling studies of anxiety disorders and depression (Dimidjian et al., 2006; Jacobson, 
Dobson, Truax, et al., 1996; Marks et al., 1998). 
 
In conclusion, we found that exposure therapy was no more effective than cognitive therapy at 
reducing problem gambling among treatment seeking adults. The findings suggest that both therapies 
were acceptable in the short-term for at least treatment completers but whether these translate into 
long-term benefits needs further assessment. The present study improved upon previous trials for 
cognitive and exposure therapies in gambling disorders  by investigating a more  extensive range of 
therapy outcomes and provided a greater level of transparency in reporting of findings such as 
determination of sample size, details of how participants were randomly assigned and details of 
therapies as they were implemented.  
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Table 1. Intervention schedule  
 
Weekly   
Sessions 
 
Cognitive Therapy (CT) 
 
Exposure Therapy (ET) 
Session 1: Pre-treatment assessment to identify problem 
gambling and any co-morbid conditions. Rationale 
and protocol of cognitive therapy explained. 
Pre-treatment assessment to identify problem gambling 
and any co-morbid conditions. Rationale and protocol 
of exposure therapy explained. 
 
Session 2: 
 
 
 
Development of participant’s measurable problems 
and goals. Analysis of a gambling session to 
identify erroneous thoughts. Commence daily self-
monitoring diary. 
Development of participant’s measurable problems and 
goals. Establish cash restrictions to ensure participant 
has no cash. First exposure task set using images. 
Commence daily self-monitoring diary. 
Session 3: 
 
Psycho-education: clarification of the concept of 
chance and establish the distinction between games 
of skill and games of chance.  
 
Review participant’s attempt at first exposure task. 
Finalise cash restriction strategies if not already in 
place. In-session imagery exposure task with therapist 
guidance.  
Session 4: 
 
Psycho-education/cognitive awareness: introduce 
ABCD (situation, thoughts, behaviour, 
consequences) model and exercises to focus on the 
gambling thoughts or ‘inner dialogue’. 
 
Review imagery exposure task. Finalise cash restriction 
strategies if not already in place. Imagery exposure task 
with therapist guidance. 
Session 5: 
 
Identifying erroneous thoughts or ‘gambling traps’ 
that lie behind emotions taking over reason using 
ABCD model. Participants are encouraged to 
challenge these thoughts, perceptions, and beliefs 
in this session.  
Review imagery exposure task. Introduction of next 
exposure task involving image and sounds of gambling-
related cues.  
Session 6: 
 
Identifying erroneous cognitions. Practical exercise 
to help participant organise and act upon thoughts  
Introduction to first of the in-vivo exposure tasks. This 
task to take place outside of participant’s usual 
gambling venue(s). The participant utilises principles of 
exposure therapy from imaginal tasks to assist in 
identifying what is happening to them at the time of the 
in-vivo task. 
Session 7: 
 
Identifying erroneous cognitions. Practical exercise 
to help participant organise and act upon thoughts 
(continued). 
Fine tuning of in-vivo exposure task outside of venue. 
Introduction to in-vivo exposure task to take place 
inside venue without cash. 
Session 8: 
 
Develop skills for challenging and casting doubt on 
the erroneous thoughts that lead to excessive 
gambling  
Fine tuning of in-vivo exposure task inside venue 
without cash. Introduction to next in-vivo task taking 
place inside a gambling venue with a small amount of 
cash. 
Session 9: 
 
Develop skills for challenging and casting doubt on 
the erroneous thoughts that lead to excessive 
gambling (continued). 
Fine tuning of in-vivo exposure task inside venue with a 
small amount of cash. Introduction to next in-vivo task 
taking place inside a gambling venue changing a small 
amount of cash for Poker machine coins. 
Session 10 Develop skills for challenging and casting doubt on 
the erroneous thoughts that lead to excessive 
gambling (continued). 
Review in-vivo exposure tasks. Introduction to next in-
vivo task taking place inside a gambling venue 
changing a small amount of cash for coins and placing 
in Poker machine. 
Sessions  
11- 12 
Explore gambling relapse and develop relapse 
prevention strategies. 
Explore gambling relapse and develop relapse 
prevention strategies. 
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Figure 1. Participant flow 
  
Assessed for eligibility (n=151) 
Excluded (n= 37) 
 primary form of gambling not EGMs 
(n= 28) 
 not gambled in previous month (n=3) 
 received psychological treatment for 
gambling n previous 12 months (n=2) 
 SOGS score <5 (n=2) 
 concurrent gambling treatment (n=2) 
Did not meet primary consent criteria (n=15) 
 declined further study assessment 
    (n=15) 
 
 
 
43 included in effectiveness analysis 
 
Discontinued intervention (n= 22) 
 participant withdrew  due to chronic physical 
health condition (n=1) 
 participant withdrew  due to jail sentence (n=1) 
 moved interstate (n=2) 
 did not attend any further appointments (n=18) 
 
 Followed -up* 
 provided data at treatment- end (n=25) 
 provided data at 1 month (n=14)  
 provide data at 3 months (n=17) 
 provided data at 6 months (n=18) 
*28 (65%) of participants provided at least one set of post-
treatment data 
 
Allocated to intervention ET (n= 49) 
 received allocated intervention (n= 43) 
 did not receive allocated intervention (did not 
attend appointment) (n= 6) 
 
Discontinued intervention (n= 14) 
 therapist-based decision to withdraw  participant 
due to Parkinson’s Disease (n=1) 
 therapist-based decision to withdraw participant 
due to unstable co-morbid mental health 
conditions (n=1) 
 did not attend any further appointments (n=12) 
 
Followed-up* 
 provided data at treatment-end (n=31) 
 provided data at 1 month (n=22)  
 provided data at 3 months (n=19) 
 did not provide data at 6 months (n=22) 
*31 (70%) of participants provided at least one set of post-
treatment data 
Allocated to intervention CT (n= 50) 
 received allocated intervention (n= 43) 
 received ET (n = 1) 
 did not receive allocated intervention (did not 
attend appointment) (n=6) 
 
 
44 included in effectiveness analysis 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=99) 
Enrolment 
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Table 2. Baseline socio-demographics and clinical characteristics 
 
 Exposure Therapy 
(n=43) 
Cognitive Therapy 
(n=44) 
Socio-demographic data   
Age (years) 45.50(12.04) 47.45(13.88) 
Female 22(50) 22(50) 
Relationship   
married/in a partnership 16(48.48) 17(51.52) 
separated/divorced/single/ 
widowed 
26(50.98) 25(49.02) 
other 1(33.33) 2(66.67) 
Employment   
employed 22(47.83) 24(52.17) 
unemployed 19(51.35) 18(48.65) 
other 2(50) 2(50) 
Clinical measures   
VGS 40.25(9.56) 41.08(11.36) 
PG (DSM-IV-TR) 43(100) 40(90.91) 
GRCS 77.08 (25.62) 74.14 (26.01) 
GUS 15.33(12.80) 12.43(12.57) 
K10 30.58(9.31) 29.91(9.42) 
WSAS 16.67(9.09) 14.36(9.66) 
Gambling behaviours
a 
  
Frequency   
weekly or less 13(48.15) 14(51.85) 
> weekly 28(49.12) 29(50.88) 
Amount spent   
$1 - $500 12(50) 12(50) 
$501 - $1000 11(40.74) 16(59.26) 
> $1000 18(52.94) 16(47.06) 
Hours, median (IQR) 15(20) 10(22) 
Abbreviations: VGS, Victorian Gambling Screen harm to self subscale; PG, Pathological gambler; DSM-IV-
TR, Diagnostic and Statistical Manual of Mental Disorders, Text Revision (4
th
 Edition); GRCS, Gambling 
Related Cognitions Scale; GUS, Gambling Urge Scale; K10, Kessler 10 Scale; WSAS, Work and Social 
Adjustment Scale. 
Data are mean (SD), or n (%) unless otherwise indicated. 
   
a
Based on gaming machine use in previous month. 
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Table 3. Treatment details 
 
 Exposure Therapy  Cognitive Therapy  P 
Views before treatment
a    
Treatment is logical 4.82(1.13) 5.11(1.22) 0.339 
Confident about treatment 4.79(0.99) 5.04(1.04) 0.345 
Views after treatment
b    
Satisfied with treatment 5.32(0.91) 5.68(0.84) 0.102 
Data are mean (SD). 
a
ET (n=33), CT (n=27) 
b
ET (n=34), CT (n=34) 
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Figure 2. Observed trajectories for cognitive and exposure therapies 
 
 
Lower scores indicate a reduction (improvement) in gambling symptom severity. 
Note: 
a 
Horizontal line is VGS cut score of 21+ (indicative of problem gambler). 
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Figure 3. Adjusted predictions of treatment completion status for combined 
cognitive and exposure groups with 95% confidence intervals 
 
 
Lower scores indicate a reduction (improvement) in gambling symptom severity. 
Note: Horizontal line is VGS cut score of 21+ (indicative of problem gambler). 
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